RXRX
Recursion is a biotechnology company leveraging AI-driven drug discovery to decode biology and accelerate the development of new medicines. By imaging cells and training machine learning models on phenomics, transcriptomics, and other omics data, they aim to shorten hit identification to IND-enabling studies and improve success rates in areas like oncology and rare diseases. The company operates from Salt Lake City, Utah, and emphasizes its Recursion Operating System and partnerships with pharma and tech leaders to advance faster, cost-efficient drug development.
No recent deals for this company.